BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6724254)

  • 1. Prospective evaluation of metabolic bone disease after jejunoileal bypass.
    Sellin JH; Meredith SC; Kelly S; Schneir H; Rosenberg IH
    Gastroenterology; 1984 Jul; 87(1):123-9. PubMed ID: 6724254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with high-dose oral vitamin D2 in patients with jejunoileal bypass for morbid obesity. Effects on calcium and magnesium metabolism, vitamin D metabolites, and faecal lag time.
    Charles P; Mosekilde L; Søndergård K; Jensen FT
    Scand J Gastroenterol; 1984 Nov; 19(8):1031-8. PubMed ID: 6335925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of vitamin D metabolism and bone mineral content after intestinal bypass for obesity. A longitudinal study.
    Rickers H; Christiansen C; Balslev I; Rødbro P
    Scand J Gastroenterol; 1984 Mar; 19(2):184-9. PubMed ID: 6609420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic osteomalacia after jejunoileal bypass surgery in a patient with primary hyperparathyroidism. A study of the change in bone morphology and vitamin D metabolites before and during treatment.
    Taylor HC; Teitelbaum SL; Lambert PW
    Gastroenterology; 1983 Sep; 85(3):735-42. PubMed ID: 6603388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral affection in asymptomatic adult patients with celiac disease.
    Mazure R; Vazquez H; Gonzalez D; Mautalen C; Pedreira S; Boerr L; Bai JC
    Am J Gastroenterol; 1994 Dec; 89(12):2130-4. PubMed ID: 7977227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone histomorphometry and vitamin D status after biliopancreatic bypass for obesity.
    Compston JE; Vedi S; Gianetta E; Watson G; Civalleri D; Scopinaro N
    Gastroenterology; 1984 Aug; 87(2):350-6. PubMed ID: 6735078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal calcium absorption as shown by stable strontium test in celiac disease before and after gluten-free diet.
    Molteni N; Bardella MT; Vezzoli G; Pozzoli E; Bianchi P
    Am J Gastroenterol; 1995 Nov; 90(11):2025-8. PubMed ID: 7485015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of liver disease in morbid obesity after small-intestinal bypass and its restoration. A case report.
    Allam C; Bala'a M; Shamma'a M
    Arch Pathol Lab Med; 1983 Apr; 107(4):195-8. PubMed ID: 6687540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The decline and fall of the jejunoileal bypass.
    Griffen WO; Bivins BA; Bell RM
    Surg Gynecol Obstet; 1983 Oct; 157(4):301-8. PubMed ID: 6623319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in intestinal structure, fat absorption and body weight after intestinal bypass for morbid obesity.
    Friedman HI; Chandler JG; Peck CC; Nemeth TJ; Odum SK
    Surg Gynecol Obstet; 1978 May; 146(5):757-67. PubMed ID: 644435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mucosal response in the excluded limb after jejunoileal bypass for morbid obesity.
    Friedman HI; Villar HV; Nemeth TJ
    Surg Gynecol Obstet; 1981 Sep; 153(3):346-50. PubMed ID: 7268609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective analysis of the arthritis syndrome and immune function in jejunoileal bypass patients.
    Leff RD; Towles W; Aldo-Benson MA; Madura J; Biegel AA
    J Rheumatol; 1983 Aug; 10(4):612-8. PubMed ID: 6620263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity.
    Mosekilde L; Melsen F; Hessov I; Christensen MS; Lund BJ; Lund BI; Sørensen OH
    Gut; 1980 Jul; 21(7):624-31. PubMed ID: 7429327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of jejunoileal bypass on oxalate and mineral metabolism in rats.
    Blaurock P; Schwille PO; Manoharan M; Scheele J; Fries W; Rümenapf G
    Eur J Surg; 1992; 158(11-12):595-602. PubMed ID: 1363064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D.
    Herlong HF; Recker RR; Maddrey WC
    Gastroenterology; 1982 Jul; 83(1 Pt 1):103-8. PubMed ID: 6978827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy following gastric bypass for the treatment of morbid obesity.
    Printen KJ; Scott D
    Am Surg; 1982 Aug; 48(8):363-5. PubMed ID: 7114602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional amblyopia associated with jejunoileal bypass surgery.
    Thompson RE; Felton JL
    Ann Ophthalmol; 1982 Sep; 14(9):848-50. PubMed ID: 7181347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium and bone metabolism after jejunal bypass operation for alimentary obesity: model for a intestinally-conditioned disorder (author's transl)].
    Kruse HP; Kuhlencordt F; Montz R; Ringe JD; Koch G
    Dtsch Med Wochenschr; 1981 Sep; 106(38):1219-23. PubMed ID: 7343280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fat and nitrogen balances after jejunoileal bypass for obesity (author's transl)].
    Beno I; Rozhold J; Chorváthová V; Prikazská M; Virsik A; Siman J
    Dtsch Z Verdau Stoffwechselkr; 1980; 40(5):184-91. PubMed ID: 7449716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.